Biolinq raised $58M in financing led by Alpha Wave Ventures for wearable biosensor tech and clinical trial on its glucose sensor
Amount Raised
$58 Million
Round Type
Funding Round
San DiegoBiotechnologyHealth CareMedical DeviceInvestors
Description
California-based Biolinq scored $58 million in financing, with the funds intended for performing a clinical trial on its glucose sensor and for FDA submission.
Quick answer
Biolinq raised $58 Million in a Funding Round round, dated April 4, 2024. Investors: Taisho Pharmaceutical, River Vest Venture Partners, Aphelion Capital, Features Capital, Senvest Management, Axa Im Alts, Niterra’s Corporate Venture Capital Fund and Alpha Wave Ventures. Biolinq is based in San Diego, California, United States.
- How much did Biolinq raise?
- Biolinq raised $58 Million in a Funding Round round on April 4, 2024.
- Who invested in Biolinq?
- Taisho Pharmaceutical, River Vest Venture Partners, Aphelion Capital, Features Capital, Senvest Management, Axa Im Alts, Niterra’s Corporate Venture Capital Fund and Alpha Wave Ventures are named as investors in this round.
- What does Biolinq do?
- Biolinq is a healthcare technology company pioneering precision multi-analyte wearable sensors to improve metabolic health.
- Where is Biolinq based and how big is it?
- Biolinq is based in San Diego, California, United States. Fundz records about 107 employees.
- Who are the decision-makers at Biolinq?
- Fundz holds 1 contact at Biolinq, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Device and Biotechnology around the same time
Companies in the same sectors as Biolinq that raised within 45 days of this round, from Fundz verified event records.
- MED-X raised $838K on May 14, 2024.
- VOCxi Health raised $800K on May 14, 2024.
- MED-X raised $250K on May 14, 2024.
- MedInTech raised $15M (Series B) on May 13, 2024.
- May Health raised $25M (Series B) on May 13, 2024.
- Nami Surgical raised $4M (Seed) on May 8, 2024.
Who to call at Biolinq, and when
A new round usually means Biolinq is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biolinq raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biolinq, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biolinq. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biolinq raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biolinq raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.